As of June 2025, AXON's current EPS stands at $4.35, according to the latest financial reports. For the year 2024, the company recorded an earnings per share (EPS) of $4.98, which marks an increase compared to its EPS of $2.37 in 2023. AXON reported an EPS of $1.14 for the quarterly report ending on Mar 31, 2025.
For 2024, Axon Enterprise's EPS was $4.98, an increase of 110.1% from $2.37 in 2023. For the fiscal quarter that ended on Mar 31, 2025, the per-share earnings was $1.14, showing a 35.6% decrease from the same quarter last year. For the twelve months ending March 2025, the EPS is $4.35. For the year 2023, the yearly earnings per share was $2.37, marking an increase of 14.5% from 2022.
Axon Enterprise has registered a decrease in EPS of 35.6% during the last 12 months (YoY, quarterly). Axon Enterprise had an average annual EPS growth rate of 246.3% during the last 5 years. Across the last decade, AXON had an average annual EPS growth of 29.3%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
EXEL Exelixis Inc | 18.58 | 176.9% | 35.1% | 11.2% |
AXON Axon Enterprise Inc | 181.09 | 110.1% | N/A | 246.3% |
SGMO Sangamo Therapeutics Inc | N/A | 66.9% | N/A | N/A |
XBIT XBiotech Inc | N/A | -55.6% | N/A | N/A |
QURE uniQure NV | N/A | 24% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.